Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Alopecia from CDK 4/6 inhibitors worsens quality of life in breast cancer patients.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Compound 15a was effective in inhibiting 5α-reductase.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Neurosteroids help balance brain signals when certain inhibitions are reduced.

Clofazimine effectively treated ashy dermatosis in a patient.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Potassium iodide prevents hair loss and reduces toxicity from thallium acetate.